USFDA DMF (Drug Master Files) are submissions made to USFDA for human drug products which provide confidential and detailed information about the facilities, processes, or articles used in the manufacturing, processing, packaging, and storing.
The DMF are required to be submitted in eCTD formats with exception of type III DMF. The DMF are not required by the regulation. DMFs are neither approved nor rejected.
Your Drug Master File’s technical sections will be reviewed by USFDA with reference to the drug applications (IND/NDA/ANDA etc.).
DMF shall be formed based on the regulation 21 CFR 314.420.
Below link can be looked into for the various list of DMF received by FDA. This database is updated on quarterly basis.
You will be able to review the details as per below table –
|ABC XYD CO.
|Drug substances and intermediates, the materials involved in their manufacturing or Drug Product
|Excipients, Colorants, Flavors, Essence, or Material Used in Their Preparation
|Reference information accepted by the FDA
US FDA accepts DMF in Electronic format. The e-submissions will have a pre-assigned number. The pre-assigned number can be requested via email.
Restricted part (Closed Part) or also called as Confidential Part
Maven ProfservDecember 21st, 2023
Scope: The newly proposed MDCG guidelines are...Read More
Maven ProfservSeptember 26th, 2023
In the field of medical device manufacturing, risk...Read More